Stevens Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Stevens Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-18,124	Closed	-$337K	–	1249
2016 Q3	$337K	Buy	+18,124	New	+$342K	0.01%	668
2016 Q1	–	Sell	-12,818	Closed	-$150K	–	1281
2015 Q4	$150K	Buy	+12,818	New	+$162K	0.01%	831
2015 Q3	–	Sell	-19,157	Closed	-$181K	–	1427
2015 Q2	$181K	Buy	19,157 +5,320	+38%	+$49.2K	0.01%	893
2015 Q1	$122K	Buy	13,837 +2,740	+25%	+$27.7K	﹤0.01%	907
2014 Q4	$111K	Sell	11,097 -1,949	-15%	-$16.7K	﹤0.01%	923
2014 Q3	$88K	Sell	13,046 -12,063	-48%	-$84.6K	﹤0.01%	939
2014 Q2	$180K	Buy	25,109 +1,981	+9%	+$15.8K	﹤0.01%	944
2014 Q1	$233K	Buy	+23,128	New	+$213K	0.01%	879

Other funds holding BEAT

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Stevens Capital Management's BEAT Position: Q4 2016 in Review

Stevens Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2016, closing a stake of 18,124 shares — an estimated $337K sold.

Stevens Capital Management first reported a position in BEAT in Q1 2014 and held it in 8 quarters. The position peaked at $337K in Q3 2016. 160 funds tracked by Wall St. Rank hold BEAT as of Q4 2016.

Stevens Capital Management reported no remaining BioTelemetry, Inc. position as of Q4 2016 after selling out during the quarter.
Stevens Capital Management sold 18,124 BioTelemetry, Inc. shares in Q4 2016, an estimated $337K.
Stevens Capital Management first reported a position in BioTelemetry, Inc. in Q1 2014 and held it in 8 quarters.
Stevens Capital Management's BioTelemetry, Inc. position peaked at $337K in Q3 2016.
160 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2016.

Based on Stevens Capital Management's 13F filing for Q4 2016, filed 7 Feb 2017.